跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
H-89
首页
药物
H-89
Experimental
Small Molecule
H-89
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
20
H
20
BrN
3
O
2
S
CAS 编号
127243-85-0
UNII ID
M876330O56
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
申请人: GUERBET SA
优先权: 2005
CN
EP
4 件公开
Organic anion transporting peptide-based cancer imaging and therapy
申请人: DA ZEN THERANOSTICS INC
优先权: 2014
CN
US
2 件公开
HUMANISED ANTIBODIES OR FUNCTIONAL FRAGMENTS THEREOF AGAINST TUMOUR ANTIGENS
申请人: CELLMABS S A
优先权: 2022
CN
WO
2 件公开
SPECIFIC HIGH-RELAXIVITY CONJUGATE COMPOUNDS FOR MAGNETIC RESONANCE IMAGING
申请人: GUERBET SA
优先权: 2004
EP
METHODS AND COMPOSITIONS FOR TARGETED IMAGING
申请人: SIGALOV ALEXANDER B
优先权: 2009
WO
Method for synthesizing 3,4-dihydropyrimidine-2(1H)-(sulfur) ketone compound by organic small molecule catalysis
申请人: UNIV XINJIANG
优先权: 2011
CN
Similar zero-order sustained-release particles applied to combination of radiotherapy and chemotherapy, preparation method and application
申请人: NANJING AOTU MEDICAL TECHNOLOGY CO LTD
优先权: 2014
CN
New form crystal of cefathiamidine compound and preparation method of new crystal-form crystal
申请人: UNIV TIANJIN
优先权: 2014
CN
Sennoside containing plant salt and preparation method thereof
申请人: WANG SHENG
优先权: 2016
CN
Novel application of PKA inhibitor H-89
申请人: UNIV TONGJI
优先权: 2016
CN
第 1 / 2 页
上一页
下一页
药物
反馈